胃肠病学和肝病学杂志

参考文献

[1]Farrell GC,Larter CZ.Nonalcoholic fatty liver disease:from steatosis to cirrhosis[J].Hepatology,2006,43(2Suppl1):S99-S112.

[2]de Alwis NM,Day CP.Non-alcoholic fatty liver disease:the mist grad-ually clears[J].J Hepatol,2008,48Suppl1:S104-S112.

[3]Fan JG,Farrell GC.Epidemiology of non-alcoholic fatty liver disease in China[J].J Hepatol,2009,50:204-210.

[4]Farrell GC,Chitturi S,Lau GK,et al.Guidelines for the assessment and management of non-alcoholic fatty liver disease in the Asia-Pacific region:executive summary[J].J Gastroenterol Hepatol,2007,22:775-777.

[5]American Gastroenterological Association.American Gastroenterological Association medical position statement:nonalcoholic fatty liver disease[J].Gastroenterology,2002,123:1702-1704.

[6]Grattagliano I,Portincasa P,Palmieri VO,et al.Managing nonalco-holic fatty liver disease:recommendations for family physicians[J].Can Fam Physician,2007,53:857-863.

[7]Eckel RH,Grundy SM,Zimmet PZ.The metabolic syndrome[J].Lancet,2005,365:1415-1428.

[8]Cohen DE,Anania FA,Chalasani N,et al.An assessment of statin safety by hepatologists[J].Am J Cardiol,2006,97:77C-81C.

[9]Vuppalanchi R,Chalasani N.Nonalcoholic fatty liver disease and non-alcoholic steatohepatitis:Selected practical issues in their evaluation and management[J].Hepatology,2009,49:306-317.

[10]Zeng MD,Fan JG,Lu LG,et al.Guidelines for the diagnosis and treatment of nonalcoholic fatty liver diseases[J].J Dig Dis,2008,9:108-112.

[11]Lok AS,McMahon BJ;Practice Guidelines Committee,American As-sociation for the Study of Liver Diseases(AASLD).Chronic hepatitis B:update of recommendations[J].Hepatology,2004,39:857-861.

[12]Angulo P.GI epidemiology:nonalcoholic fatty liver disease[J].Ali-ment Pharmacol Ther,2007,25:883-889.

[13]Fan JG,Saibara T,Chitturi S,et al.What are the risk factors and settings of non-alcoholic fatty liver disease in Asia-Pacific[J]-J Gas-troenterol Hepatol,2007,22:794-800.

[14]Cheung O,Sanyal AJ.Hepatitis C infection and nonalcoholic fatty liver disease[J].Clin Liver Dis,2008,12:573-585.

[15]Fan JG,Chitturi S.Hepatitis B and fatty liver:causal or coincidental[J]-J Gastroenterol Hepatol,2008,23:679-681.

[16]Fan JG.Strengthen the management of chronic viral hepatitis patients with fatty liver[J].Zhonghua Ganzangbing Zazhi,2009,17:801-803.范建高.重视慢性病毒性肝炎合并脂肪肝的诊断与治疗[J].中华肝脏病杂志,2009,17:801-803.

[17]Torres DM,Harrison SA.Diagnosis and therapy of nonalcoholic steatohepatitis[J].Gastroenterology,2008,134:1682-1698.

[18]Fan JG.Impact of non-alcoholic fatty liver disease on accelerated met-abolic complications[J].J Dig Dis,2008,9:63-67.

[19]Bugianesi E.Nonalcoholic fatty liver disease(NAFLD)and cardiac lipotoxicity:Another piece of the puzzle[J].Hepatology,2008,47:2-4.

[20]Kleiner DE,Brunt EM,Van Natta M,et al.Design and validation of a histological scoring system for nonalcoholic fatty liver disease[J].Hepatology,2005,41:1313-1321.

[21]Loomba R,Sirlin CB,Schwimmer JB,et al.Advances in pediatric nonalcoholic fatty liver disease[J].Hepatology,2009,50:1282-1293.

[22]Fan JG,Peng YD.Metabolic syndrome and non-alcoholic fatty liver disease:Asian definitions and Asian studies[J].Hepatobiliary Pan-creat Dis Int,2007,6:572-578.

[23]Ali R,Cusi K.Newdiagnostic and treatment approaches in non-alco-holic fatty liver disease(NAFLD)[J].Ann Med,2009,41:265-278.

[24]Fan JG.Relationship between diabetes and liver disease and strategy for its diagnosis and treatment[J].Zhonghua Tangniaobing Zazhi,2009,1:244-247.范建高.糖尿病与肝病的关系及其诊治对策[J].中华糖尿病杂志,2009,1:244-247.

[25]Fan JG,Farrell GC;Asia-Pacific working party for prevention of hep-atocellular carcinoma.Prevention of hepatocellular carcinoma in non-viral related liver diseases[J].J Gastroenterol Hepatol,2009,24:712-719.

[26]Bellentani S,Dalle Grave R,Suppini A,et al.Behavior therapy for nonalcoholic fatty liver disease:the need for a multidisciplinary ap-proach[J].Hepatology,2008,47:746-754.

[27]Hainer V,Toplak H,Mitrakou A.Treatment modalities of obesity:what fits whom[J]-Diabetes Care,2008,31Suppl2:S269-S277.

[28]Zivkovic AM,German JB,Sanyal AJ.Comparative reviewof diets for the metabolic syndrome:implications for nonalcoholic fatty liver dis-ease[J].Am J Clin Nutr,2007,86:285-300.

[29]Riley P,Al Bakir M,O'Donohue J,et al.Prescribing statins to pa-tients with nonalcoholic fatty liver disease:real cardiovascular benefits outweigh theoretical hepatotoxic risk[J].Cardiovasc Ther,2009,27:216-220.